Omicron subvariants BQ.1 and BQ.1.1 — dubbed “escape variants” for their immune evasiveness — now account for 49.7 percent of U.S. COVID-19 cases, according to the CDC’s COVID-19 data tracker weekly review published Nov. 18.
The University of California San Diego received a $20 million gift on behalf of Hanna and Mark Gleiberman to support its research into reversing the effects of glaucoma.